What's in Vantive Health LLC's pipeline?

Vantive Health LLC has 9 drugs in our index: 3 marketed, 0 filed, 3 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with Vantive Health LLC's portfolio?

Top competitors by shared drug class: Chengdu Qingshan Likang Pharmaceutical Co., Ltd, Chinese PLA General Hospital, Chinese University of Hong Kong, University of Erlangen-Nürnberg Medical School.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/vantive-health-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Vantive Health LLC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vantive Health LLC pipeline: 3 marketed, 0 filed, 3 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 3 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Extraneal	Extraneal	marketed			Other
Nutrineal	Nutrineal	marketed			Other
Dianeal	Dianeal	marketed			Other
Experimental Peritoneal Dialysis Solution	Experimental Peritoneal Dialysis Solution	phase 3	Peritoneal dialysis solution		Nephrology
Dianeal, Extraneal, Nutrineal	Dianeal, Extraneal, Nutrineal	phase 3	Peritoneal dialysis solution		Nephrology / Renal replacement therapy
Prismocitrate 18	Prismocitrate 18	phase 3	Regional anticoagulant / Citrate-based anticoagulant	Ionized calcium (Ca2+)	Nephrology / Critical Care

Therapeutic area mix

Other · 5
Nephrology · 1
Nephrology / Critical Care · 1
Nephrology / Renal replacement therapy · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Chengdu Qingshan Likang Pharmaceutical Co., Ltd · 1 shared drug class
Chinese PLA General Hospital · 1 shared drug class
Chinese University of Hong Kong · 1 shared drug class
University of Erlangen-Nürnberg Medical School · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Vantive Health LLC:

Cite this brief

Drug Landscape (2026). Vantive Health LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/vantive-health-llc. Accessed 2026-05-16.